Short Bowel Syndrome (SBS)

Short bowel syndrome is a condition in which part of the small intestine is missing or has been removed during surgery, resulting in poor absorption of nutrients. The main symptom is diarrhea.

Quick Answer

What it is

Short bowel syndrome is a condition in which part of the small intestine is missing or has been removed during surgery, resulting in poor absorption of nutrients. The main symptom is diarrhea.

Key findings

  • Grade A: Parenteral Support Reduction (Teduglutide (Gattex))
  • Grade A: Parenteral Nutrition Independence (Teduglutide (Gattex))
  • Grade A: Intestinal Absorption (Teduglutide (Gattex))

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Short Bowel Syndrome (SBS)

  • Supplements Studied:2
  • Research Trials:1
  • Total Participants:8
  • Top Supplement:Colostrum (C)
1 trials
8 ppts
2 supps · 7 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Emerging Evidence

Supporting Stack (Tier 2)

500mg daily

Provides growth factors (IGF-1, TGF-β) that support intestinal epithelial repair

4 studies | 32 participants

How It Works

This supplement protocol targets multiple biological pathways, which plays a central role in overall health and wellbeing. When this pathway functions optimally, the body maintains better short bowel syndrome (sbs) outcomes through improved cellular signaling and reduced physiological stress. This condition involves multiple interconnected physiological systems that can benefit from targeted nutritional support.

Colostrum serves as the foundation of this protocol. It provides growth factors (IGF-1, TGF-β) that support intestinal epithelial repair.

Emerging research suggests this combination approach. By addressing multiple points along the multiple pathway, these supplements work synergistically to produce better results than any single intervention alone. The combined effect helps restore balance to systems that become dysregulated in short bowel syndrome (sbs).

Rather than masking symptoms like conventional medications, these natural compounds support your body's intrinsic healing mechanisms and regulatory systems.

Allow 6-12 weeks of consistent use to evaluate effectiveness, as individual responses vary. Consistency is key. For best results, take with meals to enhance absorption unless otherwise directed and maintain regular daily use.

Generated from peer-reviewed researchSchema v

Supplements for Short Bowel Syndrome (SBS)

Sorted by strength of evidence

Detailed Outcomes

A
Parenteral Support Reduction
74% achieved 20%+ PS volume reduction at 2 years. Real-world: 36.6% reduction at 48 weeks, up to 79.3% reduction after 1 year.
large↓Improves
A
Parenteral Nutrition Independence
10-26% of patients achieved complete parenteral nutrition independence (enteral autonomy) with teduglutide treatment.
moderate↑Improves
A
Intestinal Absorption
Significant improvement in intestinal wet weight absorption capacity demonstrated in acute and chronic studies.
large↑Improves
A
Treatment Response Rate
65% response rate in Phase III clinical trials. Response defined as 20% reduction or 1-day reduction in parenteral support.
large↑Improves
A
Infusion Days per Week
Significant reduction in required parenteral infusion days per week, improving quality of life and reducing catheter-related complications.
moderate↓Improves
C
Muscle Mass
Small Improvement
1 study
small↑Improves
?
Weight
1 study
↓Improves

Research Citations (74)

Safety of Teduglutide for Managing Patients with Short Bowel Syndrome: A Systematic Review and Meta-analysis.
(2025)
PMID: 41070320
Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis.
(2024)
PMID: 38663565
Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
(2024)
PMID: 38491966
Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study
(2023)
PMID: 37416984
Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension.
(2023)
PMID: 36201060
Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
(2023)
PMID: 37364133
[Review of real-life teduglutide experience].
(2023)
PMID: 37409717
Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).
(2022)
PMID: 35654733
Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
(2022)
PMID: 35215445
Use of Teduglutide in Children With Intestinal Failure: A Systematic Review.
(2022)
PMID: 35774551

Related Conditions

Weight Loss & Maintenance

1 shared supplement · 433 outcomes

This goal refers to people with a BMI >25 attempting to reach/maintain their ideal weight. While interventions that work for people with a BMI >25 may also work for people with a lower BMI, the context is often sufficiently different that this isn't assured.

Upper Respiratory Tract Infection

1 shared supplement · 49 outcomes

Upper respiratory tract infection refers to many different infections that can occur in the upper airways, with the common cold being just one type. These infections can cause inflammation and irritation in areas like the larynx, pharynx, nose, sinuses, and nostrils.

Ulcerative Colitis

1 shared supplement · 24 outcomes

Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) in which the immune system attacks the intestinal tract, resulting in inflammation and ulcers of the colon and rectum.

Type 2 Diabetes

1 shared supplement · 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Traveler's Diarrhea

1 shared supplement · 3 outcomes

Traveler’s diarrhea causes loose, watery stools and can result from visiting areas with unclean water or poor food safety practices. Traveler’s diarrhea is a gastrointestinal infection that occurs due to the consumption of food and water contaminated with pathogens. In addition to diarrhea, symptoms can include abdominal cramping, fecal urgency, nausea, vomiting, fever, and malaise. For most people, traveler’s diarrhea will self-resolve within a few days.

Sore Throat

1 shared supplement · 2 outcomes

Sore throat (pharyngitis) refers to inflammation of the mucous membranes of the oropharynx, resulting in scratchiness or pain in the throat. In the most cases, the cause is an infection, either viral (e.g., the common cold, the flu) or bacterial (e.g., group A streptococcus).

Running Performance

1 shared supplement · 116 outcomes

This goal refers to outcomes specifically related to running, such as running speed and endurance. Related faculties are muscular endurance, cardiovascular and pulmonary health, and conditioning.

Runners' Health

1 shared supplement · 17 outcomes

This goal refers to the prevention and management of running-associated health issues such as sickness and soreness after running, gut health, the rate of injuries, etc.